medigraphic.com
ISSN 1029-3043 (Electronic)

2017, Number 2

<< Back Next >>

Medicentro 2017; 21 (2)

Platelet-rich plasma: a versatile therapeutic alternative in ocular diseases

Cárdenas ML, Negrin CY

Language: Spanish
References: 47
Page: 90-100
PDF size: 498.52 Kb.


ABSTRACT

Introduction: platelet-rich plasma appears as a new strategy of cellular repair with successful results in diverse medical fields. It is a non-toxic substance since this is an autologous product; it is also biocompatible, biodegradable and adverse effects are barely noticeable. Due to its wide application, it is used in the treatment of certain ocular diseases, in which currently used therapies have limitations.
Objective: to present cellular therapy as a new scientific discipline, since its transdisciplinary character, by means of updating of knowledge on the benefits of the regenerative medicine in the treatment of some ocular affections.
Methods: it was made a review of the current bibliography available as complete texts or abstracts in both English and Spanish languages in databases such as PubMed, Ebsco, Google Scholar and Scielo, as well as, new articles published in prestigious and specialized journals were consulted.
Conclusions: regenerative medicine offers new, effective and reliable treatment strategies for patients with ocular affections such as, dry eye syndrome, torpid corneal ulcers and post-LASIK syndrome; it is also used to restore lacrimal function, in the treatment of glaucoma and even as bioadhesive material. However, it is necessary to carry on doing studies that allow us to establish their indications in other ocular diseases.


REFERENCES

  1. Alió JL, Rodriguez Zunino AE, Luque Río A. Plasma rico en plaquetas (E-PRP) en el tratamiento de la patología de la superficie ocular. Arch Soc Esp Oftalmol. 2011;7(14):167-81.

  2. Elisseeff J, Madrid MG, Lu Q, Jeremy Chae J, Guo Q. Future Perspectives for Regenerative Medicine in Ophthalmology. Middle East Afr J Ophthalmol [internet]. 2013 Jan.-Mar. [citado 5 mar. 2015];20(1):[aprox. 8 p.]. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/3617526

  3. Nugent RB, Lee GA. Ophthalmic use of blood-derived products. Surv Ophthalmol. 2015;60(5):406-434.

  4. Rodríguez Flores J, Palomar Gallego MA, Torres García-Denche J. Plasma rico en plaquetas: fundamentos biológicos y aplicaciones en cirugía maxilofacial y estética facial. Rev Esp Cir Oral Maxilofac. 2012;34(1):8-17.

  5. Alio JL, Rodríguez AE, Wróbel Dudzińska D. Eye platelet-rich plasma in the treatment of ocular surface disorders. Curr Opin Ophthalmol. 2015;26(4):325-32.

  6. Herrera-Rojas MA, Gómez- Almaguer D. ¿Magia y arte en la Medicina? A propósito del plasma rico en plaquetas. Rev Hematol Méx. 2013;14:109-10.

  7. López JS, Mata E, Sánchez-Carnerero F, González ML, Martín C. Plaquetas: estructura, función y aplicaciones clínicas. Arch Soc Esp Oftalmol. 2012;7(13):155-66.

  8. Alió JL, Ainalich-Montiel F, Rodríguez AE. The role of “eye platelet rich plasma” (E_PRP) for wound healing in ophtalmology. Curr Pharm Biotechnol. 2012;13:1257-65.

  9. Escobar HM. Terapia de bioestimulación con plasma rico en plaquetas para el envejecimiento cutáneo. Rev Argent Dermatol [internet]. 2012 ene.-mar. [citado 30 nov. 2015];93(1):[aprox. 13 p.]. Disponible en: http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S1851-300X2012000100008&lng=es&nrm=iso&tlng=es

  10. Willemsen JC, van der Lei B, Vermeulen KM, Stevens HP. The effects of platelet-rich plasma on recovery time and aesthetic outcome in facial rejuvenation: preliminary retrospective observations. Aesthetic Plast Surg [internet]. 2014 Oct. [citado 11 abr. 2015];38(5):[aprox. 7 p.]. Disponible en: http://link.springer.com/article/10.1007/s00266-014-0361-z

  11. Ramírez García LK, Ríos Rodríguez ME, Gómez Cabrera CG, Rojas Rondón I, Gracia Arboleda JC. Bioestimulación cutánea periocular con plasma rico en plaquetas. Rev Cubana Oftalmol. 2015;28(1):97-109.

  12. Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent. 2001;10(4):225-8.

  13. Anitua E, Sánchez M, Orive G, Andia I. Delivering growth factors for therapeutics. Trends in Pharmacol Sci. 2008;29(1):37-41.

  14. Middleton KK, Barro V, Muller B, Terada S, Fu FH. Evaluation of the effects of platelet-rich plasma (PRP) therapy involved in the healing of sports-related soft tissue injuries. Iowa Orthop J [internet]. 2012 [citado 5 mar. 2015]; 32:[aprox. 13 p.]. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/3565396

  15. Creaney L, Wallace A, Curtis M, Connell D. Growth factor-based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single-blind, randomised trial of autologous blood injections versus platelet-rich plasma injections. Br J Sports Med. 2011 Sep;45(12):966-71.

  16. Redler LH, Thompson SA, Hsu SH, Ahmad CS, Levine WN. Platelet-rich plasma therapy: a systematic literature review and evidence for clinical use. Phys Sports Med. 2011;39(1):42-51.

  17. Ficek K, Kamiński T, Wach E, Cholewiński J, Cięszczyk P. Application of Platelet Rich Plasma in Sports Medicine. J Hum Kinet [internet]. 2011 Dec. 25 [citado 17 abr. 2015];30:[aprox. 13 p.]. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/3588629

  18. Almdahl SM, Veel T, Halvorsen P, Vold MB, Molstad Pl. Randomized prospective trial of saphenous vein harvest site infection after wound closure with and without topical application of autologous platelet-rich plasma. Eur J Cardiothorac Surg. 2011 Jan;39(1):44-48.

  19. Oie Y, Nishida K. Regenerative Medicine for the Cornea. Biomed Res Int [internet]. 2013 Dec. 17 [citado 18 feb. 2015];2013:[aprox. 8 p.]. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/3876767

  20. Nakamura T, Inatomi T, Sotozono C, Koizumi N, Kinoshita S. Ocular surface reconstruction using stem cell and tissue engineering. Prog Retin Eye Res. 2016;51:187-207.

  21. Arnalich F, Rodriguez AE, Luque-Rio A, Alio JL. Solid Platelet Rich Plasma in Corneal Surgery. Ophthalmol Ther. 2016 May 14 [citado 18 jul. 2016];5(1):[aprox. 15 p.]. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/4909678

  22. Fukaya M, Ito A. A New Economic Method for Preparing Platelet-rich Plasma. Plast Reconstr Surg Glob Open [internet]. 2014 Jul. 9 [citado 11 abr. 2015];2(6):[aprox. 8 p.]. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/4174234

  23. Araki J, Jona M, Eto H. Optimized preparation method of platelet-concentrated plasma and noncoagulating platelet-derived factor concentrates: maximization of platelet concentration and removal of fibrinogen. Tissue Eng Part C Methods. 2012;18(3):176-85.

  24. Rossani G, Hernández I, Alcolea JM, Castro-Sierra R, Pérez-Soto W, Trelles MA. Tratamiento de quemaduras mediante plasma rico en plaquetas (PRP): Parte I. Cir Plást Iberolatinoam [internet]. 2014 abr.-jun. [citado 8 sep. 2014];40(2):[aprox. 10 p.]. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0376-78922014000200015&lng=es

  25. Pan Q, Angelina A, Zambrano A, Marrone M, Stark W, Heflin T, et al. Autologous serum eye drops for dry eye. Cochrane Database Syst Rev [internet]. 2013 Aug. 27 [citado 18 jul. 2015];8:[aprox. 16 p.]. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/4007318

  26. Urzua CA, Vázquez DH, Huidobro A, Hernández H, Alfaro J. Randomized double-blind clinical trial of autologous serum versus artificial tears in dry eye syndrome. Current Eye Res. 2012;37(8):684-8.

  27. Weisbach V, Dietrich T, Kruse FE. HIV and hepatitis B/C infections in patients donating blood for use as autologous serum eye drops. Br J Ophthalmol. 2007;91:1724-5.

  28. Petznick A, Tong L, Chung R, Wang JC, Koh M, Salleh R, et al. Autologous plasma eye drops prepared in a closed system: a treatment for dry eye. Eye. 2013;27(9):1102.

  29. Dogru M, Tsubota K. Pharmacotherapy of dry eye. Expert Opin Pharmacother. 2011;12(3):325-34.

  30. Dogru M, Nakamura M, Shimazaki J, Tsubota K. Changing trends in the treatment of dry-eye disease. Expert Opin Investig Drugs. 2013;22(12):1581-601.

  31. Alio JL, Pastor S, Ruiz-Colecha J, Rodríguez A, Artola A. Treatment of ocular surface syndrome after LASIK with autologous platelet-rich plasma. J Refract Surg. 2007;23(6):617-9.

  32. Javaloy J, Alió JL, Rodríguez AE, Vega A, Muñoz G. Effect of platelet-rich plasma in nerve regeneration after LASIK. J Refract Surg. 2013;29(3):213-9.

  33. Alio JL, Abad M, Artola A, Rodríguez-Prats JL, Pastor S, Ruiz-Colecha J. Use of autologous platelet-rich plasma in the treatment of dormant corneal ulcers. Ophthalmology. 2007;114(7):1286-93.

  34. Pezzotta S, Del Fante C, Scudeller L, Cervio M, Antoniazzi ER, Perotti C. Autologous platelet lysate for treatment of refractory ocular GVHD. Bone Marrow Transplant. 2012;47:1558-63.

  35. Avila MY. Restoration of human lacrimal function following platelet-rich plasma injection. Cornea. 2014;33:18-21.

  36. You S, Avidan O, Tariq A. Role of epitelial-mesenchimal transition in repair of the lacrimal gland after experimentally induced injury. Invest Ophthalmol Vis Sci. 2012;53:126-35.

  37. Ortuño-Prados VJ, Alio JL. Treatment of a neurotrophic corneal ulcer with solid platelet-rich plasma and Tutopatch®. Arch Soc Esp Oftalmol. 2011;86(4):121-3.

  38. Alio JL, Rodríguez AE, Martínez LM. Bovine pericardium membrane (Tutopatch) combined with solid platelet-rich plasma for the management of perforated corneal ulcers. Cornea. 2013;32(5):619-24.

  39. Konstantinidis A, Hero M, Nanos P, Panos GD. Efficacy of autologous platelets in macular hole surgery. Clin Ophthalmol [internet]. 2013 Apr. 17 [citado 21 mayo 2015];7:[aprox. 6 p.]. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/3632626

  40. Kapoor KG, Khan AN, Tieu BC, Khurshid GS. Revisiting autologous platelets as an adjuvant in macular hole repair: chronic macular holes without prone positioning. Ophthalmic Surg Lasers Imaging. 2012;43(4):291-5.

  41. Gehring S, Hoerauf H, Laqua H, Kirchner H, Klüter H. Preparation of autologous platelets for the ophthalmologic treatment of macular holes. Transfusion. 1999;39(2):144-88.

  42. Márquez de Aracena R. Tratamiento de las quemaduras oculares por productos químicos mediante aplicación tópica y subconjuntival de plasma rico en factores regeneradores. Estudio comparativo. Emergencias. 2013;25:393-6.

  43. López García J, Murube del Castillo J. Suero autólogo y derivados hemáticos en Oftalmología. En: Comunicación solicitada en el 87 Congreso de la Sociedad Española de Oftalmología. Madrid: Ediciones Ingenio; 2011.

  44. Kolko M. Present and New Treatment Strategies in the Management of Glaucoma. Open Ophthalmol J [internet]. 2015 May 15 [citado 6 dic. 2015];9:[aprox. 12 p.]. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/4460216

  45. Ganceviciene R, Liakou AI, Theodoridis A, Makrantonaki E, Zouboulis CC. Skin anti-aging strategies. Dermatoendocrinol [internet]. 2012 Jul. 1;4(3):[aprox. 12 p.]. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/3583892

  46. Mehryan P, Zartab H, Rajabi A, Pazhoohi N, Firooz A. Assessment of efficacy of platelet-rich plasma (PRP) on infraorbital dark circles and crow's feet wrinkles. J Cosmet Dermatol [internet]. 2014 Mar. 18;13(1):[aprox. 7 p.]. Disponible en: http://onlinelibrary.wiley.com/doi/10.1111/jocd.12072/full

  47. Oh IY, Kim BJ, Kim MN. Depressed Facial Scars Successfully Treated with Autologous Platelet-Rich Plasma and Light-Emitting Diode Phototherapy at 830 nm. Ann Dermatol. 2014 Jun.;26(3):417-8.




2020     |     www.medigraphic.com